[1] |
Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse[J]. Int Urogynecol J, 2013,24(11):1783-1790. doi: 10.1007/s00192-013-2169-9.
doi: 10.1007/s00192-013-2169-9
pmid: 24142054
|
[2] |
Dällenbach P. To mesh or not to mesh: a review of pelvic organ reconstructive surgery[J]. Int J Womens Health, 2015,7:331-343. doi: 10.2147/IJWH.S71236.
doi: 10.2147/IJWH.S71236
pmid: 25848324
|
[3] |
Li Z, Xu T, Li Z, et al. An epidemiologic study of pelvic organ prolapse in rural Chinese women: a population-based sample in China[J]. Int Urogynecol J, 2019,30(11):1925-1932. doi: 10.1007/s00192-018-03859-9.
doi: 10.1007/s00192-018-03859-9
pmid: 30685785
|
[4] |
中华医学会妇产科学分会妇科盆底学组. 盆腔器官脱垂的中国诊治指南(2020年版)[J]. 中华妇产科杂志, 2020,55(5):300-306. doi: 10.3760/cma.j.cn112141-20200106-00016.
|
[5] |
Jelovsek JE, Maher C, Barber MD. Pelvic organ prolapse[J]. Lancet, 2007,369(9566):1027-1038. doi: 10.1016/S0140-6736(07)60462-0.
doi: 10.1016/S0140-6736(07)60462-0
pmid: 17382829
|
[6] |
Delorme E. What transvaginal meshes (TVM) surgery tells us about conflicts of interest[J]. J Gynecol Obstet Hum Reprod, 2020,49(1):101636. doi: 10.1016/j.jogoh.2019.101636.
doi: 10.1016/j.jogoh.2019.101636
pmid: 31520751
|
[7] |
Duport C, Duperron C, Delorme E. Anterior and middle pelvic organ prolapse repair using a six tension-free strap low weight transvaginal mesh: long-term retrospective monocentric study of 311 patients[J]. J Gynecol Obstet Hum Reprod, 2019,48(3):143-149. doi: 10.1016/j.jogoh.2018.11.008.
doi: 10.1016/j.jogoh.2018.11.008
pmid: 30508648
|
[8] |
Luo DY, Yang TX, Shen H. Long term Follow-up of Transvaginal Anatomical Implant of Mesh in Pelvic organ prolapse[J]. Sci Rep, 2018,8(1):2829. doi: 10.1038/s41598-018-21090-w.
doi: 10.1038/s41598-018-21090-w
pmid: 29434209
|
[9] |
King J. Real story behind transvaginal mesh[J]. Intern Med J, 2020,50(5):527-529. doi: 10.1111/imj.14831.
doi: 10.1111/imj.14831
pmid: 32431034
|
[10] |
范晓东. 女性盆底功能障碍性疾病的手术治疗进展[J]. 国际妇产科学杂志, 2019,46(1):27-31. doi: 10.3969/j.issn.1674-1870.2019.01.006.
|
[11] |
Ray S, Clifton MM, Koo K. Inaccuracies in News Media Reporting About the 2019 US Food and Drug Administration Ban on Transvaginal Mesh for Pelvic Organ Prolapse Repair[J]. Urology,2020 May 18:S0090-4295(20)30553-7.. doi: 10.1016/j.urology.2020.05.009. Epub ahead of print.
pmid: 33823174
|
[12] |
Yassa M, Doğan O. The International Urogynecological Association/International Continence Society classification of complications of prosjournal and graft insertion: Pros and cons and a review of the literature[J]. J Turk Ger Gynecol Assoc, 2020,21(1):57-61. doi: 10.4274/jtgga.galenos.2019.2019.0036.
doi: 10.4274/jtgga.galenos.2019.2019.0036
pmid: 31362485
|
[13] |
Withagen MI, Vierhout ME, Hendriks JC, et al. Risk factors for exposure, pain, and dyspareunia after tension-free vaginal mesh procedure[J]. Obstet Gynecol, 2011,118(3):629-636. doi: 10.1097/AOG.0b013e31822ada95.
pmid: 21860293
|
[14] |
Ubertazzi EP, Soderini H, Saavedra Sanchez A, et al. Long-term outcomes of transvaginal mesh (TVM) In patients with pelvic organ prolapse: A 5-year follow-up[J]. Eur J Obstet Gynecol Reprod Biol, 2018,225:90-94. doi: 10.1016/j.ejogrb.2018.03.060.
doi: 10.1016/j.ejogrb.2018.03.060
pmid: 29680466
|
[15] |
Lo TS, Tan YL, Cortes EF, et al. Clinical outcomes of mesh exposure/extrusion: presentation, timing and management[J]. Aust N Z J Obstet Gynaecol, 2015,55(3):284-290. doi: 10.1111/ajo.12340.
pmid: 26044791
|
[16] |
Niu K, Lu YX, Shen WJ, et al. Risk Factors for Mesh Exposure after Transvaginal Mesh Surgery[J]. Chin Med J (Engl), 2016,129(15):1795-1799. doi: 10.4103/0366-6999.186631.
|
[17] |
Allègre L, Callewaert G, Alonso S, et al. Long-term outcomes of a randomized controlled trial comparing trans-obturator vaginal mesh with native tissue repair in the treatment of anterior vaginal wall prolapse[J]. Int Urogynecol J, 2020,31(4):745-753. doi: 10.1007/s00192-019-04073-x.
doi: 10.1007/s00192-019-04073-x
pmid: 31506808
|
[18] |
Veit-Rubin N, De Tayrac R, Cartwright R, et al. Abnormal vaginal microbiome associated with vaginal mesh complications[J]. Neurourol Urodyn, 2019,38(8):2255-2263. doi: 10.1002/nau.24129.
doi: 10.1002/nau.24129
pmid: 31402478
|
[19] |
Wu PY, Chang CH, Shen MR, et al. Seeking new surgical predictors of mesh exposure after transvaginal mesh repair[J]. Int Urogynecol J, 2016,27(10):1547-1555. doi: 10.1007/s00192-016-2996-6.
pmid: 26992722
|
[20] |
Dykes N, Karmakar D, Hayward L. Lightweight transvaginal mesh is associated with lower mesh exposure rates than heavyweight mesh[J]. Int Urogynecol J, 2020,31(9):1785-1791. doi: 10.1007/s00192-020-04270-z.
doi: 10.1007/s00192-020-04270-z
pmid: 32125493
|
[21] |
Wei D, Wang P, Niu X, et al. Comparison between laparoscopic uterus/sacrocolpopexy and total pelvic floor reconstruction with vaginal mesh for the treatment of pelvic organ prolapse[J]. J Obstet Gynaecol Res, 2019,45(4):915-922. doi: 10.1111/jog.13908.
doi: 10.1111/jog.13908
pmid: 30652385
|
[22] |
Kamei J, Yazawa S, Yamamoto S, et al. Risk factors for surgical site infection after transvaginal mesh placement in a nationwide Japanese cohort[J]. Neurourol Urodyn, 2018,37(3):1074-1081. doi: 10.1002/nau.23416.
doi: 10.1002/nau.23416
pmid: 29527737
|
[23] |
Takahashi S, Obinata D, Sakuma T, et al. Tension-free vaginal mesh procedure for pelvic organ prolapse: a single-center experience of 310 cases with 1-year follow up[J]. Int J Urol, 2010,17(4):353-358. doi: 10.1111/j.1442-2042.2010.02469.x.
doi: 10.1111/j.1442-2042.2010.02469.x
pmid: 20202001
|
[24] |
Hüsch T, Mager R, Ober E, et al. Quality of life in women of non-reproductive age with transvaginal mesh repair for pelvic organ prolapse: A cohort study[J]. Int J Surg, 2016,33 Pt A: 36-41. doi: 10.1016/j.ijsu.2016.07.062.
pmid: 27465100
|
[25] |
Gonocruz SG, Hayashi T, Tokiwa S, et al. Transvaginal surgery using self-cut mesh for pelvic organ prolapse: 3-year clinical outcomes[J]. Int J Urol, 2019,26(7):731-736. doi: 10.1111/iju.13984.
pmid: 31066098
|
[26] |
Kato K, Suzuki S, Kawanishi H, et al. POSTOPERATIVE CHRONIC PAIN FOLLOWING MESH AND NON-MESH REPAIR OF PELPIC ORGAN PROLAPSE[J]. Nihon Hinyokika Gakkai Zasshi, 2018,109(2):90-95. doi: 10.5980/jpnjurol.109.90.
doi: 10.5980/jpnjurol.109.90
pmid: 31006747
|
[27] |
Morselli S, Li Marzi V, Verrienti P, et al. Transvaginal mesh surgery for pelvic organ prolapse does not affect sexual function at long term follow up[J]. Eur J Obstet Gynecol Reprod Biol, 2019,240:282-287. doi: 10.1016/j.ejogrb.2019.07.027.
doi: 10.1016/j.ejogrb.2019.07.027
pmid: 31352129
|
[28] |
Jacquetin B, Fatton B, Rosenthal C, et al. Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 3-year prospective follow-up study[J]. Int Urogynecol J, 2010,21(12):1455-1462. doi: 10.1007/s00192-010-1223-0.
pmid: 20683579
|
[29] |
Oride A, Kanasaki H, Hara T, et al. Postoperative Outcomes Following Tension-Free Vaginal Mesh Surgery for Pelvic Organ Prolapse: A Retrospective Study[J]. Urol J, 2019,16(6):581-585. doi: 10.22037/uj.v0i0.4631.
pmid: 31630387
|
[30] |
Chughtai B, Mao J, Asfaw TS, et al. Long-term Device Outcomes of Mesh Implants in Pelvic Organ Prolapse Repairs[J]. Obstet Gynecol, 2020,135(3):591-598. doi: 10.1097/AOG.0000000000003689.
doi: 10.1097/AOG.0000000000003689
pmid: 32028486
|